TCT 279: Treatment of In-Stent Restenosis With Sirolimus- Versus Paclitaxel-Coated Balloons

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Abiomed; AstraZenca; Bayer AG; Daiichi-Sankyo/Elil Lilly and Company; SIS Medical; Boehringer Ingelheim; Novartis
• Grant Support/Research Contract - Abbott Vascular; Vifor; SIS Medical; Biosensors